Teresa Kaserer, Cancer Research UK Cancer Therapeutics Unit, The Institute of Cancer Research London Title: Computational identification of mutations conferring drug resistance to targeted cancer therapies https://www.uibk.ac.at/pharmazie/phchem/camd/staff/teresa-kaserer.html
Natascha Kleiter, Section of Translational Cell Genetics, Medical University Innsbruck Title: The nuclear orphan receptor NR2F6 as a new cancer immune checkpoint Natascha Kleiter has characterized NR2F6 as an intracellular immune checkpoint, directly repressing transcription of cytokine genes in T cells relevant for cancer cell rejection and therefore enhancing tumor immune surveillance. https://phd-school.i-med.ac.at/phd-programs/doctoralprogram/molecular-cell-biology
Matthias Kieslinger, formerly Helmholtz Zentrum Munich, German Research Center for Environmental Health; now Vetmeduni Vienna, Internal Medicine Small Animals Title: The Ebf (early B cell factor) family of transcription factors https://www.vetmeduni.ac.at/de/interne-kleintiere/ueber-uns/personen/projektmitarbeiter/
Alice Giustacchini, University College London, Department of Cell and Developmental Biology Title: Hematopoietic Stem Cell and Leukemia Stem Cell Biology https://www.ucl.ac.uk/biosciences/departments/cdb
Christian Stockmann, Universität Zürich, Medizinische Fakultät, Anatomisches Institut Title: Immune cell-driven angiogenesis affecting organ remodelling during tissue hypoxia Christian Stockmann’s research group aims to decipher how immune cell-driven angiogenesis affects organ remodeling during tissue hypoxia and also on the role of hypoxia-inducible factors in distinct immune cell subsets and their impact on tissue fibrosis after […]